Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparative and Cost Effectiveness of Treatment Modalities for Hepatocellular Carcinoma in SEER-Medicare
Authors
Keywords
Sorafenib, Tace, Unstaged Patient, Resection Patient, Selective Internal Radiation Therapy
Journal
PHARMACOECONOMICS
Volume 32, Issue 1, Pages 63-74
Publisher
Springer Nature
Online
2013-11-28
DOI
10.1007/s40273-013-0109-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
- (2012) Hashem B. El-Serag GASTROENTEROLOGY
- Inverse Probability Weighted Least Squares Regression in the Analysis of Time-Censored Cost Data: An Evaluation of the Approach Using SEER-Medicare
- (2012) Robert I. Griffiths et al. VALUE IN HEALTH
- Medical Care Costs and Survival Associated With Hepatocellular Carcinoma Among the Elderly
- (2011) Leigh Ann White et al. Clinical Gastroenterology and Hepatology
- Management of hepatocellular carcinoma with transarterial chemoembolization in the era of systemic targeted therapy
- (2011) Riccardo Lencioni CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean?
- (2011) Joshua J Shaw et al. Expert Review of Gastroenterology & Hepatology
- Systemic Treatment of Hepatocellular Carcinoma: Dawn of a New Era?
- (2010) Andrew X. Zhu ANNALS OF SURGICAL ONCOLOGY
- Underutilization of therapy for hepatocellular carcinoma in the medicare population
- (2010) Shimul A. Shah et al. CANCER
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
- (2010) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Predictors of Survival After Resection of Early Hepatocellular Carcinoma
- (2009) Hari Nathan et al. ANNALS OF SURGERY
- Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
- (2009) Sean F. Altekruse et al. JOURNAL OF CLINICAL ONCOLOGY
- Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy
- (2008) Melanie B. Thomas et al. ANNALS OF SURGICAL ONCOLOGY
- The burden of illness associated with hepatocellular carcinoma in the United States
- (2008) Kathleen Lang et al. JOURNAL OF HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started